Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule
- PMID: 2471777
- PMCID: PMC2189344
- DOI: 10.1084/jem.169.6.2233
Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule
Abstract
Neural cell adhesion molecule (N-CAM) is a membrane glycoprotein expressed on neural and muscle tissues that is involved in homotypic adhesive interactions. We have demonstrated that N-CAM also is expressed on hematopoietic cells, and is recognized by the anti-Leu-19 mAb. Leu-19 is preferentially expressed on NK cells and T lymphocytes that mediate MHC-unrestricted cytotoxicity, but is also present on some myeloid leukemia cell lines. On NK cells, T cells, the KG1a.5 hematopoietic cell line, and a neuroblastoma cell line, Leu-19 is a approximately 140-kD polypeptide with N-linked carbohydrates and abundant sialic acid residues. Sequential immunoprecipitation and peptide mapping demonstrated that the Leu-19 and N-CAM molecules expressed on leukocyte and neuroblastoma cell lines are similar structures. These findings suggest that the Leu-19 antigen on leukocytes may be involved in cell adhesion, analogous to the function on N-CAM on neural cells.
Similar articles
-
Involvement of CD56 (NKH-1/Leu-19 antigen) as an adhesion molecule in natural killer-target cell interaction.J Exp Med. 1989 Nov 1;170(5):1757-61. doi: 10.1084/jem.170.5.1757. J Exp Med. 1989. PMID: 2478655 Free PMC article.
-
Molecular and functional analysis of human natural killer cell-associated neural cell adhesion molecule (N-CAM/CD56).J Immunol. 1991 Jun 15;146(12):4421-6. J Immunol. 1991. PMID: 1710251
-
Regenerating and denervated human muscle fibers and satellite cells express neural cell adhesion molecule recognized by monoclonal antibodies to natural killer cells.Ann Neurol. 1992 Jan;31(1):46-52. doi: 10.1002/ana.410310109. Ann Neurol. 1992. PMID: 1371910
-
Antigenic, functional, and molecular genetic studies of human natural killer cells and cytotoxic T lymphocytes not restricted by the major histocompatibility complex.Fed Proc. 1986 Nov;45(12):2823-8. Fed Proc. 1986. PMID: 3095151 Review.
-
The CD2-LFA-3 and LFA-1-ICAM pathways: relevance to T-cell recognition.Immunol Today. 1989 Dec;10(12):417-22. doi: 10.1016/0167-5699(89)90039-X. Immunol Today. 1989. PMID: 2482743 Review.
Cited by
-
CD56/NCAM mediates cell migration of human NK cells by promoting integrin-mediated adhesion turnover.bioRxiv [Preprint]. 2023 Nov 22:2023.11.21.567714. doi: 10.1101/2023.11.21.567714. bioRxiv. 2023. Update in: Mol Biol Cell. 2024 May 1;35(5):ar64. doi: 10.1091/mbc.E23-12-0463. PMID: 38045340 Free PMC article. Updated. Preprint.
-
Heterogeneity of human natural killer cells in the spleen.Immunology. 1990 Jan;69(1):166-70. Immunology. 1990. PMID: 2179129 Free PMC article.
-
Phenotypic and clinical heterogeneity of CD56-positive acute nonlymphoblastic leukemia.Ann Hematol. 1992 Feb;64(2):78-82. doi: 10.1007/BF01715349. Ann Hematol. 1992. PMID: 1372833
-
Natural Killer Cell-Based Immunotherapy against Glioblastoma.Int J Mol Sci. 2023 Jan 20;24(3):2111. doi: 10.3390/ijms24032111. Int J Mol Sci. 2023. PMID: 36768432 Free PMC article. Review.
-
The Impact of NK Cell-Based Therapeutics for the Treatment of Lung Cancer for Biologics: Targets and Therapy.Biologics. 2021 Jul 7;15:265-277. doi: 10.2147/BTT.S290305. eCollection 2021. Biologics. 2021. PMID: 34262255 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous